WY
51
-2
EOG
49
-6
JPM
55
-2
DHI
49
-5
UNM
48
-5
EW
46
-4
BRK.B
31
-2
KMX
49
-5
PRGO
43
-3
WU
10
-4
IRM
26
-2
LOW
34
-5
IPG
45
-4
FTI
64
-2
LEN
34
-7
SEE
45
-4
EXR
30
-7
DIS
58
-2
CTSH
42
-3
PGR
33
-2
WY
51
-2
EOG
49
-6
JPM
55
-2
DHI
49
-5
UNM
48
-5
EW
46
-4
BRK.B
31
-2
KMX
49
-5
PRGO
43
-3
WU
10
-4
IRM
26
-2
LOW
34
-5
IPG
45
-4
FTI
64
-2
LEN
34
-7
SEE
45
-4
EXR
30
-7
DIS
58
-2
CTSH
42
-3
PGR
33
-2
Financhill
Back

Neurocrine Biosciences 10K Form

Buy
60

NBIX
Neurocrine Biosciences

Last Price:
$133.55
Seasonality Move:
3.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q NBIX/Neurocrine Biosciences Quarterly
2023-10-31 10Q NBIX/Neurocrine Biosciences Quarterly
2023-08-01 10Q NBIX/Neurocrine Biosciences Quarterly
2023-05-03 10Q NBIX/Neurocrine Biosciences Quarterly
2022-11-01 10Q NBIX/Neurocrine Biosciences Quarterly
2022-08-04 10Q NBIX/Neurocrine Biosciences Quarterly

Receive NBIX News And Ratings

See the #1 stock for the next 7 days that we like better than NBIX

NBIX Financial Statistics

Sales & Book Value

Annual Sales: $2.4B
Cash Flow: $54.1M
Price / Cash Flow: 27.56
Annual Sales: $25.63
Price / Book: 5.12

Profitability

EPS (TTM): 2.95000
Net Income (TTM): $305.8M
Gross Margin: $2.3B
Return on Equity: 12%
Return on Assets: 8.63%

Neurocrine Biosciences Earnings Forecast

Key Neurocrine Biosciences Financial Ratios

  • The Gross Profit Margin over the past 29 years for NBIX is 98.56%.
  • The Selling, General & Administrative Expenses for NBIX have been equal to 42.76% of Gross Profit Margin.
  • The Research & Development expenses have been 31.04% of Revenue.
  • The Interest Expense is 37.09% of Operating Income.
  • The Net Earning history of NBIX is 14.49% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 14 years.

Neurocrine Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NBIX
CUSIP: 64125C
Website: neurocrine.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.13
Quick Ratio: 2.79

Price-to-Earnings

Trailing P/E Ratio: 39.89
Forward P/E Ratio: 15.65

NBIX Technical Analysis vs Fundamental Analysis

Buy
60
Neurocrine Biosciences (NBIX) is a Buy

Is Neurocrine Biosciences a Buy or a Sell?